✦ LIBER ✦

Interleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis

✍ Scribed by Fang Wang, Lingxiao Xu, Xiaoke Feng, Dunming Guo, Wenfeng Tan, Miaojia Zhang

Book ID: 119915562
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 901 KB
Volume: 14
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar4067

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD14+ cell–derived IL-29 modulates proin

CD14+ cell–derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation

✍ S. He; T. Li; H. Chen; W. Ma; Q. Yao; H. Yang; H. Wang; F. Wang; C. Zhao; P. Yan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

The levels of leukemia inhibitory factor

The levels of leukemia inhibitory factor in synovial tissues of patients with rheumatoid arthritis: inflammation and other proinflammatory cytokines

✍ Hiroyuki Enomoto; Seiji Saito; Hiroshi Yabe; Yoshiaki Toyama; Taisuke Tomatu 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 436 KB

Expression of interleukin-22 in rheumato

Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine

✍ Hidekazu Ikeuchi; Takashi Kuroiwa; Noriyuki Hiramatsu; Yoriaki Kaneko; Keiju Hir 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

In vitro induction of proinflammatory cy

In vitro induction of proinflammatory cytokine secretion by juvenile rheumatoid arthritis synovial fluid immune complexes

✍ James N. Jarvis; Wenlian Wang; Heide T. Moore; Lin Zhao; Chengsu Xu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

Ganoderma lucidumpolysaccharide peptide

Ganoderma lucidumpolysaccharide peptide reduced the production of proinflammatory cytokines in activated rheumatoid synovial fibroblast

✍ Y. W. Ho; J. S. L. Yeung; P. K. Y. Chiu; W. M. Tang; Z. B. Lin; R. Y. K. Man; C. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 304 KB

Reduction of synovial sublining layer in

Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate

✍ David Kane; Martina Gogarty; John O'Leary; Ivan Silva; Niamh Bermingham; Barry B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

## Abstract ## Objective Methotrexate is one of the most commonly used disease‐modifying antirheumatic drugs in the management of psoriatic arthritis (PsA). Despite the differences between the inflammation in PsA and rheumatoid arthritis (RA), the effects of methotrexate on the synovium have been